Mirogabalin besilate
Tier C — Watch / tradeMirogabalin besilate · all drugs expiring in 2030 →
Targets：CACNA2D1
Brand：Tarlige
Indications (approved)：Diabetic neuropathy, Postherpetic neuralgia, Peripheral nervous system disorder
Regional status
Factories producing this API2
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
2 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| MRIO-001 | 106-95-6Available | 3-bromoprop-1-ene |
| MRIO-002 | 106-95-6Available | 3-bromoprop-1-ene |
| MRIO-003 | 1138245-48-3Available | ethyl 4-ethyl-3-hydroxyhept-6-enoate |
| MRIO-004 | 1138245-49-4Available | 4-ethyl-3-hydroxyhept-6-enoic acid |
| MRIO-005 | 62327-21-3Available | tert-butyl 2-(dimethoxyphosphoryl)acetate |
| MRIO-006 | 1138245-50-7Available | (E)-tert-butyl 2-(3-ethylbicyclo[3.2.0]hept-3-en-6-ylidene)acetate |
| MRIO-007 | 1415817-42-3Available | tert-butyl 2-(3-ethyl-6-(nitromethyl)bicyclo[3.2.0]hept-3-en-6-yl)acetate |
| MRIO-008 | 1138246-18-0Available | tert-butyl 2-((1R,5S,6S)-3-ethyl-6-(nitromethyl)bicyclo[3.2.0]hept-3-en-6-yl)acetate |
| MRIO-009 | 1138246-20-4Available | tert-butyl 2-((1R,5S,6S)-6-(((tert-butoxycarbonyl)amino)methyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetate |
| Code | CAS No. | Intermediate |
|---|---|---|
| MRIO-010 | 1235479-61-4Available | (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one |
| MRIO-011 | 105-53-3Available | diethyl malonate |
| MRIO-012 | 1644251-28-4Available | diethyl 2-((1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-ylidene)malonate |
| MRIO-013 | 1644251-34-2Available | diethyl 2-((1R,5S,6R)-6-cyano-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)malonate |
| MRIO-014 | 1644251-58-0Available | 2-((1R,5S,6S)-6-cyano-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid |
| MRIO-015 | 1644251-62-6Available | phenylmethanamine 2-((1R,5S,6S)-6-cyano-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetate |
Frequently asked questions
What are the approved indications of Mirogabalin besilate?
Approved indications include: Diabetic neuropathy, Postherpetic neuralgia, Peripheral nervous system disorder.
When does the Mirogabalin besilate patent expire?
Based on public sources, the Mirogabalin besilate patent expires in 2030.
How many synthesis routes are recorded for Mirogabalin besilate?
2 synthesis routes are recorded; the shortest is 5 steps with 36.19 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Mirogabalin besilate intermediates?
14 intermediate CAS of Mirogabalin besilate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Mirogabalin besilate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29